| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |